Inactive Instrument

SENSODETECT Share Price Swiss Exchange

Equities

SE0003037456

Advanced Medical Equipment & Technology

End-of-day quote Swiss Exchange
- SEK - Intraday chart for SENSODETECT

Financials

Sales 2022 820K 77.85K 6.5M Sales 2023 2.26M 214K 17.91M Capitalization 24.99M 2.37M 198M
Net income 2022 -8M -759K -63.42M Net income 2023 -8M -759K -63.42M EV / Sales 2022 44.1 x
Net cash position 2022 660K 62.66K 5.23M Net Debt 2023 4.54M 431K 35.96M EV / Sales 2023 13.1 x
P/E ratio 2022
-4.07 x
P/E ratio 2023
-2.81 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 99%
More Fundamentals * Assessed data
Audientes, SensoDetect to Launch Health Services in Saudi Arabia MT
Audientes A/S and SensoDetect AB Announce Strategic Collaboration to Enhance Mental and Hearing Health Solutions in Saudi Arabia and Beyond CI
SensoDetect Aktiebolag Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
SensoDetect AB Appoints Saleh and Löfström to Medicinal Advisory Board CI
SensoDetect Aktiebolag Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
SensoDetect Aktiebolag Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
SensoDetect Aktiebolag Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
SensoDetect Aktiebolag Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
SensoDetect Aktiebolag Auditor Raises 'Going Concern' Doubt CI
SensoDetect Aktiebolag Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 CI
SensoDetect Aktiebolag Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
SensoDetect Aktiebolag Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
SensoDetect Aktiebolag Auditor Raises 'Going Concern' Doubt CI
SensoDetect Aktiebolag Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
SensoDetect Aktiebolag Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021 CI
More news
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO 63 -
Corporate Officer/Principal - -
Members of the board TitleAgeSince
Director/Board Member 65 -
Chairman 57 -
Director/Board Member - 02/19/02
More insiders
SensoDetect AB is a Sweden-based company within healthcare sector. Its primary product SensoDetect BERA is a tool for investigation of brainstem function. It measures brainstem activity and provides brainstem audiometry measuring the brain’s response to sound. Brainstem audiogram of a patient is compared to the ones of healthy persons and discrepancy areas are related to psychiatric diagnoses schizophrenia and attention deficit hyperactivity disorder (ADHD). The product is designed for such areas as psychiatry, pharmaceutical industry and research. The Company’s primary markets comprise the United Kingdom, Germany, Sweden and Bolivia. The main shareholders are Avanza Pension and Nordnet Pensionsforsakring.
More about the company